The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis

Cancer
Patricia HarndenMalcolm D Mason

Abstract

Clinically localized prostate cancer is associated with a wide variation in biologic behavior, and men with the less aggressive form of the disease may never develop symptoms. There has been a rise in prostate cancer incidence in countries in which the blood test for prostatic-specific antigen (PSA) is common, and concerns have been expressed that this may be because of the increased detection of indolent disease, subjecting these men to unnecessary treatment and associated side effects. For the current review, the authors conducted a systematic evaluation of the literature regarding the outcomes of men who were diagnosed on the basis of a small volume of cancer in prostatic biopsies. The results indicated that, despite differences in study design and reporting, a significant proportion of patients with microfocal cancer, regardless of how it was defined, had adverse pathologic findings and a significant risk of PSA recurrence after undergoing radical prostatectomy. Biochemical and clinical recurrences also were observed after radiotherapy or watchful waiting. The authors concluded that patients with microfocal carcinoma on biopsy should be advised that their disease is not necessarily "insignificant" and should be counseled ac...Continue Reading

References

Jan 11, 1986·Lancet·J E McNealT A Stamey
May 1, 1996·British Journal of Urology·V RaveryL Boccon-Gibod
Aug 28, 1996·JAMA : the Journal of the American Medical Association·G S GerberG W Chodak
Jul 17, 1998·British Journal of Urology·T A GardnerJ Steckel
Sep 28, 1998·JAMA : the Journal of the American Medical Association·P C AlbertsenM J Barry
May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
May 16, 2002·BJU International·S R J BottUNKNOWN Contributors to the UCL Hospitals' Trust Radical Prostatectomy Database
May 23, 2002·International Journal of Clinical Oncology·Yuzo FuruyaMotoyuki Masai
Jul 4, 2002·Journal of the National Cancer Institute·Ruth EtzioniEric J Feuer
Jun 26, 2003·International Journal of Urology : Official Journal of the Japanese Urological Association·Hideaki MiyakeHiroshi Eto
Jun 19, 2004·Scandinavian Journal of Urology and Nephrology·Stephen S ConnollyDavid M Quinlan
Jul 15, 2005·Actas urologicas españolas·M Montesino SemperA Santiago González de Garibay
Aug 30, 2005·European Urology·L M Boccon-GibodL A Boccon-Gibod
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aditya BardiaMatthew P Goetz
Oct 10, 2006·BJU International·Theresa M KoppiePeter T Scardino
Nov 25, 2006·BMJ : British Medical Journal·Timothy J Wilt, Ian M Thompson
Nov 30, 2006·Scandinavian Journal of Urology and Nephrology·M Tarján, T Tot
Dec 13, 2006·Radiologic Clinics of North America·Oguz Akin, Hedvig Hricak
Feb 27, 2007·BMJ : British Medical Journal·Douglas G Altman, J Martin Bland

❮ Previous
Next ❯

Citations

Jun 24, 2008·World Journal of Urology·Helen O'Donnell, Chris Parker
Sep 8, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Roula AlbadineGeorge J Netto
May 7, 2010·Journal of Endourology·Emilie LecornetMark Emberton
Jan 11, 2011·Ultrasonic Imaging·Liang ZhaiKathryn R Nightingale
Mar 29, 2014·Current Opinion in Urology·Abi KanthabalanHashim U Ahmed
Feb 4, 2009·Current Opinion in Urology·Vladimir Mouraviev, John F Madden
Jun 1, 2012·Current Opinion in Urology·Anthony N HoangPeter A Pinto
Feb 4, 2010·Expert Review of Proteomics·Samantha E T LarkinPaul A Townsend
Jul 10, 2012·Urology·Jean-Baptiste BeauvalUNKNOWN Members of Committee of Cancerology of the French Association of Urology (CCAFU)
May 24, 2011·European Urology·Guillaume PloussardTheodorus H van der Kwast
Mar 31, 2010·Ultrasound in Medicine & Biology·Liang ZhaiKathryn R Nightingale
Oct 4, 2015·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·S Bassard, J-L Mege
Feb 1, 2008·Cancer·Peter N Schlegel
Jan 4, 2012·Histopathology·Glen Kristiansen
Oct 17, 2012·CA: a Cancer Journal for Clinicians·Oguz AkinHedvig Hricak
Oct 30, 2013·BJU International·James ThompsonUNKNOWN USANZ
May 31, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Jae Dong ChungKyung Do Kim
Oct 16, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Sunao ShojiToyoaki Uchida
Dec 19, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Nageen YousafSami Siraj
Jan 7, 2014·Prostate International·Seung Hwan LeeByung Ha Chung
Jun 25, 2013·The Journal of Urology·Annerleim Walton DiazPeter A Pinto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.